filmov
tv
BCMA-Targeted Therapies in Multiple Myeloma
Показать описание
Review of BCMA-targeted therapies including BiTE, CAR T cells and antibody-drug conjugates in myeloma.
OncLive
cancer
oncology
Рекомендации по теме
0:02:24
BCMA-Targeted Therapies in Multiple Myeloma
0:04:37
Future of BCMA-Targeted Therapies in Multiple Myeloma
0:02:00
Treating multiple myeloma resistant to BCMA-targeted therapy
0:03:24
BCMA-targeted Therapies and Multiple Myeloma
0:01:40
Dr. Cortes on the Advantage of BCMA-Targeted Therapy in Multiple Myeloma
0:01:16
Dr. Avigan on BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma
0:01:38
Using BCMA-targeting agents in earlier lines of treatment for multiple myeloma
0:55:48
Hitting the BCMA Target in Multiple Myeloma
0:02:31
The value of BCMA-targeting therapy in multiple myeloma: current applications and future outlooks
0:01:29
Sequencing BCMA-targeted therapies in myeloma
0:01:58
Blood Cancer Research: Targeted therapy in multiple myeloma
0:10:06
Safety and Efficacy of Fully Human BCMA CAR T Cells in Combination with a Gamma Secretase Inhibitor
0:03:47
BCMA-Targeted Therapy in RRMM: Future Challenges and BiTE
0:17:05
BCMA in Multiple Myeloma: Emerging Targeted Solutions
0:01:02
Managing progression after BCMA-targeted therapy in R/R multiple myeloma
0:02:33
The Role of Anti-BCMA Therapies
0:00:53
Incorporating BCMA-targeted CAR-T therapy in the frontline treatment of multiple myeloma
0:09:05
Targeted Treatment Options in Multiple Myeloma
0:08:22
Case 4: BCMA-Targeted CAR T-Cell Therapy in Myeloma
1:20:14
Betting on BCMA Therapy in Multiple Myeloma
0:05:24
BCMA-Targeted Therapy in RRMM: Management of Adverse Events
0:08:13
BCMA-targeted BiTEs for multiple myeloma
0:03:19
BCMA-Targeted Therapy in RRMM: Results From the DREAMM-1 Trial
0:11:01
Targeting BCMA for R/R myeloma
join shbcf.ru